The SMARTFLOW™ clinical team at the Minneapolis Heart Institute Foundation (MHIF) at Allina Health Minneapolis Heart ...

EDEN PRAIRIE, Minn., April 08, 2021 (GLOBE NEWSWIRE) -- Bringing transportable care directly to patients who are too critically-ill to be moved could be the difference between life and death. New ...

EDEN PRAIRIE, Minn., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) was honored at the 2021 R&D 100 Awards last month, with its Aquadex SmartFlow® system selected as a winner in the ...

Nuwellis, Inc. NUWE shares are trending on Wednesday night. Shares of the Minnesota-based medical technology company climbed ...

MEMPHIS, Tenn.--(BUSINESS WIRE)--SurgiVision, Inc., a leader in interventional MRI-guided systems, announced today at the American Association of Neurological Surgeons (AANS) annual meeting that its ...

"Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy and entry into a key market ...

Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the clinical evaluation of AngioInsight's investigational AngioAI+™ platform.

Aquadex was pivotal in the care of a 74-year-old patient with severe multi-organ complications (STEMI, catastrophic hypoxic respiratory failure, cardiogenic shock and multisystem organ failure).

SMARTFLOW represents AngioInsight's first prospective, multicenter clinical study evaluating the performance of AngioAI+ and bringing together internationally recognized leaders in coronary physiology ...

Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the clinical evaluation of AngioInsight's investigational AngioAI+™ platform.